Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.

The Journal of clinical endocrinology and metabolism - 1 Aug 2017

Lee Jie-Jen, Wang Tao-Yeuan, Liu Chien-Liang, Chien Ming-Nan, Chen Ming-Jen, Hsu Yi-Chiung, Leung Ching-Hsiang, Cheng Shih-Ping

Abstract excerpt

Context: Dipeptidyl peptidase IV (DPP4) is overexpressed in thyroid cancer and certain malignancies. Furthermore, DPP4 has been identified as a discriminatory marker for thyroid cancer. However, it remains unclear whether DPP4 expression plays a prognostic role. Objective: The aim of this study was to investigate the expression and function of DPP4 in thyroid cancer and the mechanisms involved. Design: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dipeptidyl Peptidase 4

Share to Gene Knockdown Techniques

Share to Thyroid Cancer, Papillary

Share to Transforming Growth Factor beta

Share to Tumor Stem Cell Assay

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 28575350
DOI: 10.1210/jc.2017-00346

Genes

DPP4
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.PMID 28575350Read ↗

DPP4 Promotes Papillary Thyroid Cancer Progression by Regulating the Infiltration and Exhaustion of CD8+ T cellsSemantic proximity Read ↗

Gene expression profiling identifies potential molecular markers of papillary thyroid carcinomaSemantic proximity Read ↗

Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4Semantic proximity Read ↗

Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.Semantic proximity Read ↗

MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1Semantic proximity Read ↗

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.Semantic proximity Read ↗

miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathwaySemantic proximity Read ↗

Functional Toll-like Receptor 4 Overexpression in Papillary Thyroid Cancer by MAPK/ERK–Induced ETS1 Transcriptional ActivitySemantic proximity Read ↗

MicroRNA‐384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACBSemantic proximity Read ↗

Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer.Semantic proximity Read ↗

Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib.Semantic proximity Read ↗

Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.